U.S. markets open in 3 hours 58 minutes

Voyager Therapeutics, Inc. (VYGR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.7200-0.0700 (-1.46%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
171,128
171,128
104,391
7,619
10,135
Operating Expense
143,744
143,744
156,070
98,714
81,998
Operating Income
27,384
27,384
-51,679
-91,095
-71,863
Net Non Operating Interest Income Expense
1,659
1,659
6,457
3,310
1,227
Other Income Expense
7,698
7,698
1,625
-683
-62
Pretax Income
36,741
36,741
-43,597
-88,468
-70,698
Tax Provision
0
0
0
-180
0
Net Income Common Stockholders
36,741
36,741
-43,597
-88,288
-70,698
Diluted NI Available to Com Stockholders
36,741
36,741
-43,597
-88,288
-70,698
Basic EPS
-
-
-1.21
-2.75
-2.64
Diluted EPS
-
-
-1.21
-2.75
-2.64
Basic Average Shares
-
-
35,898
32,066
26,804
Diluted Average Shares
-
-
35,898
32,066
26,804
Total Operating Income as Reported
27,384
27,384
-51,679
-91,095
-71,863
Total Expenses
143,744
143,744
156,070
98,714
81,998
Net Income from Continuing & Discontinued Operation
36,741
36,741
-43,597
-88,288
-70,698
Normalized Income
36,741
36,741
-43,597
-88,288
-70,698
Interest Income
1,659
1,659
6,457
-
1,227
Net Interest Income
1,659
1,659
6,457
3,310
1,227
EBIT
27,384
27,384
-51,679
-91,095
-71,863
EBITDA
31,201
-
-
-
-
Reconciled Depreciation
3,817
3,817
2,765
2,117
1,595
Net Income from Continuing Operation Net Minority Interest
36,741
36,741
-43,597
-88,288
-70,698
Normalized EBITDA
31,201
31,201
-48,914
-88,978
-70,268
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0